May 19, 2021
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: | Infinity Pharmaceuticals, Inc. |
Registration Statement on Form S-3 (File No. 333-256096)
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Infinity Pharmaceuticals, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-256096), so that it may become effective at 4:00 p.m. Eastern time on May 21, 2021, or as soon thereafter as practicable.
Very truly yours, | |||
INFINITY PHARMACEUTICALS, INC. | |||
By: | /s/ Seth A. Tasker | ||
Name: | Seth A. Tasker | ||
Title: | Senior Vice President, Chief Business Officer & Secretary |